Laurie P. Havanec
CIK 1807757 · View on SEC EDGAR ↗
Insider
First SEC filing: Dec. 9, 2022 · Latest: Dec. 9, 2022
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 32 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | AWK | A | 1,374 | — | — | 5,369 Direct | +34.39% | Acquired | (price as of 2026-08-21) |
| May 14, 2025 | AWK | A | 1,308 | — | — | 3,995 Direct | +48.68% | Acquired | (price as of 2026-08-21) |
| May 15, 2024 | AWK | A | 1,234 | — | — | 2,687 Direct | +84.93% | Acquired | (price as of 2026-08-21) |
| April 1, 2024 | CVS | A | 39,184 | $79.56 | $3,117,479 | 39,184 Direct | — | Acquired | 17.6% (price as of 2026-08-21) |
| April 1, 2024 | CVS | A | 9,426 | $79.56 | $749,933 | 9,426 Direct | — | Acquired | 17.6% (price as of 2026-08-21) |
| April 1, 2024 | CVS | F | 7,630 | $79.56 | $607,043 | 37,553 Direct | -16.89% | Disposed | 17.6% (price as of 2026-08-21) |
| Feb. 26, 2024 | CVS | F | 6,698 | $76.43 | $511,928 | 45,183 Direct | -12.91% | Disposed | 22.4% (price as of 2026-08-21) |
| Feb. 12, 2024 | CVS | A | 16,817 | — | — | 37,203 Direct | +82.49% | Acquired | (price as of 2026-08-21) |
| May 10, 2023 | AWK | A | 1,035 | — | — | 1,453 Direct | +247.61% | Acquired | (price as of 2026-08-21) |
| April 1, 2023 | CVS | A | 51,959 | $74.31 | $3,861,073 | 51,959 Direct | — | Acquired | 25.9% (price as of 2026-08-21) |
| Feb. 27, 2023 | CVS | F | 4,046 | $85.77 | $347,025 | 20,386 Direct | -16.56% | Disposed | 9.1% (price as of 2026-08-21) |
| Dec. 7, 2022 | AWK | A | 413 | — | — | 418 Direct | +8260.00% | Acquired | (price as of 2026-08-21) |
| April 1, 2022 | CVS | A | 21,829 | $101.09 | $2,206,694 | 21,829 Direct | — | Acquired | -7.4% (price as of 2026-08-21) |
| Feb. 26, 2022 | CVS | F | 5,233 | $104.30 | $545,802 | 9,754 Direct | -34.92% | Disposed | -10.3% (price as of 2026-08-21) |
| April 1, 2021 | CVS | A | 27,643 | $74.30 | $2,053,875 | 27,643 Direct | — | Acquired | 26.0% (price as of 2026-08-21) |
| Feb. 26, 2021 | CVS | A | 44,033 | $68.13 | $2,999,968 | 44,033 Direct | — | Acquired | 37.4% (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | M | 1,854 | — | — | 0 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | M | 3,148 | — | — | 0 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | F | 539 | $65.59 | $35,353 | 12,370 Direct | -4.18% | Disposed | 9.7% (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | M | 1,854 | $65.59 | $121,604 | 12,909 Direct | +16.77% | Acquired | 9.7% (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | F | 916 | $65.59 | $60,080 | 11,055 Direct | -7.65% | Disposed | 9.7% (price as of 2026-08-21) |
| Jan. 2, 2021 | OTIS | M | 3,148 | $65.59 | $206,477 | 11,971 Direct | +35.68% | Acquired | 9.7% (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | M | 110 | — | — | 2,510 Direct | -4.20% | Disposed | (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | M | 196 | — | — | 4,461 Direct | -4.21% | Disposed | (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | F | 110 | $66.94 | $7,363 | 8,823 Direct | -1.23% | Disposed | 7.4% (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | M | 110 | $66.94 | $7,363 | 8,933 Direct | +1.25% | Acquired | 7.4% (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | F | 196 | $66.94 | $13,120 | 8,823 Direct | -2.17% | Disposed | 7.4% (price as of 2026-08-21) |
| Nov. 30, 2020 | OTIS | M | 196 | $66.94 | $13,120 | 9,019 Direct | +2.22% | Acquired | 7.4% (price as of 2026-08-21) |
| July 1, 2020 | OTIS | M | 11,247 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| July 1, 2020 | OTIS | F | 4,471 | $55.78 | $249,392 | 9,029 Direct | -33.12% | Disposed | 28.9% (price as of 2026-08-21) |
| July 1, 2020 | OTIS | M | 11,247 | — | — | 13,500 Direct | +499.20% | Acquired | (price as of 2026-08-21) |
| June 1, 2020 | OTIS | A | 19,800 | — | — | 19,800 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2024 | CVS | Stock Option | Common Stock (39,184) | $79.56 | April 1, 2034 | 39,184 | Acquired |
| April 1, 2023 | CVS | Stock Option [F3] | Common Stock (51,959) | $74.31 | April 1, 2033 | 51,959 | Acquired |
| April 1, 2022 | CVS | Stock Option | Common Stock (21,829) | $101.09 | April 1, 2032 | 21,829 | Acquired |
| April 1, 2021 | CVS | Stock Option | Common Stock (27,643) | $74.30 | April 1, 2031 | 27,643 | Acquired |
| Jan. 2, 2021 | OTIS | Restricted Stock Units | Common Stock (1,854) | — | — | 1,854 | Acquired |
| Jan. 2, 2021 | OTIS | Restricted Stock Units | Common Stock (3,184) | — | — | 3,148 | Acquired |
| Nov. 30, 2020 | OTIS | Restricted Stock Units | Common Stock | — | — | 110 | Disposed |
| Nov. 30, 2020 | OTIS | Restricted Stock Units | Common Stock | — | — | 196 | Disposed |
| July 1, 2020 | OTIS | Restricted Stock Units (RSUs) | Common Stock (11,247) | — | — | 11,247 | Disposed |
| June 1, 2020 | OTIS | Restricted Stock Units (RSUs) | Common Stock (19,800) | — | — | 19,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.